Is the Importance of Achieving Stable Disease Different between Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Cytotoxic Agents in the Second-Line Setting for Advanced Non-small Cell Lung Cancer?

Takayasu Kurata, Keitaro Matsuo, Minoru Takada, Masaaki Kawahara, Masahiro Tsuji, Yuka Matsubara, Nagahiro Otani, Shigeki Matsuyama, Kenya Muraishi, Tetsuya Fujita,

Journal of Thoracic Oncology · 2006 · 16 citations · 63 references

DOIFull text

Open access

Concepts

References

63